145 related articles for article (PubMed ID: 11568974)
21. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
22. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.
Kuroki T; Yendamuri S; Trapasso F; Matsuyama A; Aqeilan RI; Alder H; Rattan S; Cesari R; Nolli ML; Williams NN; Mori M; Kanematsu T; Croce CM
Clin Cancer Res; 2004 Apr; 10(7):2459-65. PubMed ID: 15073125
[TBL] [Abstract][Full Text] [Related]
23. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells.
Pao MM; Tsutsumi M; Liang G; Uzvolgyi E; Gonzales FA; Jones PA
Hum Mol Genet; 2001 Apr; 10(9):903-10. PubMed ID: 11309363
[TBL] [Abstract][Full Text] [Related]
24. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
25. Relationship between aberrant methylation of FAS promoter and biological behavior of bladder urothelial carcinoma.
Li W; Xia D; Wang Y; Li Y; Xue Y; Wu X; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):794-798. PubMed ID: 22173501
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.
Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA
Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649
[TBL] [Abstract][Full Text] [Related]
27. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
30. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
Mavis CK; Morey Kinney SR; Foster BA; Karpf AR
Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
32. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.
Huang G; Koshkina NV; Kleinerman ES
Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Tokizane T; Shiina H; Igawa M; Enokida H; Urakami S; Kawakami T; Ogishima T; Okino ST; Li LC; Tanaka Y; Nonomura N; Okuyama A; Dahiya R
Clin Cancer Res; 2005 Aug; 11(16):5793-801. PubMed ID: 16115918
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic control of NF-κB-dependent FAS gene transcription during progression of myelodysplastic syndromes.
Ettou S; Humbrecht C; Benet B; Billot K; d'Allard D; Mariot V; Goodhardt M; Kosmider O; Mayeux P; Solary E; Fontenay M
Mol Cancer Res; 2013 Jul; 11(7):724-35. PubMed ID: 23604035
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
37. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
38. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
39. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE
Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
